119 related articles for article (PubMed ID: 6688640)
1. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
Ogoshi K; Kondoh Y; Nakasaki H; Tajima T; Mitomi T
Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer].
Ogoshi K; Kondo Y; Akiba Y; Sugihara T; Ko S; Noto T; Makuuchi H; Tajima T; Mitomi T
Gan No Rinsho; 1984 Aug; 30(10):1299-302. PubMed ID: 6481966
[TBL] [Abstract][Full Text] [Related]
5. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
Nishio S; Ozaki Y; Wada S; Kawakita J; Maekawa M
Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels of sialic acid and other glycoproteins in stomach cancer, with special reference to cellular immunity].
Ogoshi K; Kondoh Y; Tajima T; Mitomi T
Nihon Shokakibyo Gakkai Zasshi; 1983 Nov; 80(11):2352-6. PubMed ID: 6323798
[No Abstract] [Full Text] [Related]
7. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors].
Shibasaki K; Soga K; Toshima M; Aikawa K; Tsuruya T; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K
Shigaku; 1989 Aug; 77(2):701-11. PubMed ID: 2489324
[TBL] [Abstract][Full Text] [Related]
9. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
Kageyama T; Oyabu H; Ohshiba S
Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
Takada M
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
[TBL] [Abstract][Full Text] [Related]
11. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum acid soluble glycoproteins (ASP) and immunosuppressive acidic protein (IAP) in inflammatory diseases and liver diseases].
Shibasaki K; Soga K; Toshima M; Aikawa K; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K; Kato J
Shigaku; 1989 Oct; 77(3):1031-41. PubMed ID: 2489330
[TBL] [Abstract][Full Text] [Related]
13. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Sato T; Sakata Y; Tamura K
Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of a serum immunosuppressive (IS) substance in various diseases].
Mannami T; Fuchimoto S; Amamiya S; Morioka S; Tanaka S; Tanaka N; Konaga E; Orita K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2104-12. PubMed ID: 6191693
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
Battaglia F; Scambia G; Panici PB; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
[TBL] [Abstract][Full Text] [Related]
16. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
Kikuchi S
Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive factor in the sera of patients with stomach cancer--with special reference to IAP (immunosuppressive acidic protein)].
Shimizu N; Izumi A; Ozaki Y; Kanayama H; Maeda M; Koga S
Gan No Rinsho; 1982; 28(2):125-8. PubMed ID: 7182557
[No Abstract] [Full Text] [Related]
18. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
[TBL] [Abstract][Full Text] [Related]
19. Importance of glycoproteins in human cancer.
Patel PS; Raval GN; Rawal RM; Patel MM; Balar DB; Patel DD
Indian J Biochem Biophys; 1997; 34(1-2):226-33. PubMed ID: 9343956
[TBL] [Abstract][Full Text] [Related]
20. Perchloric acid-soluble serum glycoprotein as an index for tumor cell burden in the early detection of cancer.
Hakim AA; Joseph CE; Silvetti AN; Medak H
Cancer Detect Prev; 1982; 5(2):201-8. PubMed ID: 6290061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]